First Annual Global Clinical Trials Update

This webinar will provide information on ALS/MND treatments currently in Phase 3 Clinical Trials. We will hear directly about timelines, where the sites are, other programs offered, and who to contact if more information is needed. Moderated by Gethin Thomas, Executive Director, Research – MND Australia, hear from AB Science, Amylyx, Biogen, Clene Nanomedicine, Ferrer, Ionis, and more!